Multinational Firms Outlay New Product Introductions

Published: 2005-01-14 07:00:00

Updated: 2005-01-14 07:00:00

The multinational pharmaceutical companies operating in Korea are entering the new year with their business plans to introduce new product lineups to the market, in addition to strengthen the existing products to further expand their market shares.

Pfizer Korea tops the list with five new product introductions, including Spiriva for the treatment of chronic obstructive pulmonary disease (COP...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.